So far, clinical trials havent resulted in regulatory approval, and pharmaceutical companies havent been motivated to invest in further development
It may also be useful in the recovery from spinal cord injuries, although more research is needed to fully understand its potential in this area
How Does GHK-Cu Compare to Established Acne Research Compounds
Fresenius Kabi specificity was required under J0610 but is no longer necessary under J0612) Dosage and volume: Total milliliters administered, converted to milligrams using the products concentration, since J0612 bills 1 unit per 10 mg Route of administration: Intravenous (IV), with notation of infusion method (peripheral vs central line where relevant) Clinical indication: The diagnosis justifying the administration, mapped to the ICD-10 code on the claim Prescribing or ordering clinician: Name, credentials, and NPI of the practitioner who ordered the drug Date and time of administration: Supports the claim date and drug administration CPT code billing Lot number and expiration date: Required for controlled documentation in outpatient infusion settings Common billing errors and how to avoid them This is where J0610 claims most often go wrong
This near-parity is the basis for the model of ghkcu as a physiological copper shuttle rather than an inert chelator
GHK-Cu is a naturally occurring tripeptide that binds strongly to copper (II) ions
